Abstract:Natural killer (NK) cells have gained attention as a promising adoptive cell therapy platform for their potential to improve cancer treatments. NK cells offer distinct advantages over T-cells, including major histocompatibility complex class I (MHC-I)-independent tumor recognition and low risk of toxicity, even in an allogeneic setting. Despite this tremendous potential, challenges persist, such as limited in vivo persistence, reduced tumor infiltration, and low absolute NK cell numbers. This review outlines several strategies aiming to overcome these challenges. The developed strategies include optimizing NK cell expansion methods and improving NK cell antitumor responses by cytokine stimulation and genetic manipulations. Using K562 cells expressing membrane IL-15 or IL-21 with or without additional activating ligands like 4-1BBL allows "massive" NK cell expansion and makes multiple cell dosing and "off-the-shelf" efforts feasible. Further improvements in NK cell function can be reached by inducing memory-like NK cells, developing chimeric antigen receptor (CAR)-NK cells, or isolating NK-cell-based tumor-infiltrating lymphocytes (TILs). Memory-like NK cells demonstrate higher in vivo persistence and cytotoxicity, with early clinical trials demonstrating safety and promising efficacy. Recent trials using CAR-NK cells have also demonstrated a lack of any major toxicity, including cytokine release syndrome, and, yet, promising clinical activity. Recent data support that the presence of TIL-NK cells is associated with improved overall patient survival in different types of solid tumors such as head and neck, colorectal, breast, and gastric carcinomas, among the most significant. In conclusion, this review presents insights into the diverse strategies available for NK cell expansion, including the roles played by various cytokines, feeder cells, and culture material in influencing the activation phenotype, telomere length, and cytotoxic potential of expanded NK cells. Notably, genetically modified K562 cells have demonstrated significant efficacy in promoting NK cell expansion. Furthermore, culturing NK cells with IL-2 and IL-15 has been shown to improve expansion rates, while the presence of IL-12 and IL-21 has been linked to enhanced cytotoxic function. Overall, this review provides an overview of NK cell expansion methodologies, highlighting the current landscape of clinical trials and the key advancements to enhance NK-cell-based adoptive cell therapy.

Adoptive NK cell therapy: a potential revolutionary approach in longevity therapeutics

Combining adoptive NK cell infusion with a dopamine-releasing peptide reduces senescent cells in aged mice

Natural killer cells immunosenescence and the impact of lifestyle management

Characterization of age-related immune features after autologous NK cell infusion: Protocol for an open-label and randomized controlled trial

Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions

Functionally Diverse NK-Like T Cells Are Effectors and Predictors of Successful Aging

Rejuvenation Strategy for Inducing and Enhancing Autoimmune Response to Eliminate Senescent Cells

Advances in Nanotherapy for Targeting Senescent Cells

Targeting Senescent Cells for a Healthier Longevity: the Roadmap for an Era of Global Aging

Natural Killer Cells: A Promising Kit in the Adoptive Cell Therapy Toolbox

The host environment is responsible for aging-related functional NK cell deficiency

The impact of ageing on natural killer cell function and potential consequences for health in older adults

The ageing immune system as a potential target of senolytics

Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies

Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy

Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies

Immunotherapeutic approach to reduce senescent cells and alleviate senescence‐associated secretory phenotype in mice

A Comprehensive Exploration of Gene, Cellular, and Pharmacological Anti-Aging Strategies

Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma

Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities

Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan